Literature DB >> 33227515

Unusual cause at an unusual time-Powassan virus rhombencephalitis.

Igor Dumic1, Cristian Madrid2, Danilo Vitorovic3.   

Abstract

Powassan virus lineage II (POWV) is an emerging tick-borne neurotropic pathogen, transmitted to humans by the bite of infected Ixodes scapularis ticks. In the United States, the disease is most prevalent in the Northeast and the upper Midwest and occurs mostly during the spring and summer months when tick activity is the highest. Some patients infected with POWV develop severe encephalitis, with high mortality. We report the case of a 42-year-old healthy man who developed progressive diplopia and dysarthria in December following a deer hunting trip. Routine blood work was unrevealing and MRI was normal. Extensive work-up for infectious, autoimmune, and paraneoplastic causes was positive only for POWV. The patient was treated with supportive care and intravenous corticosteroids, with an excellent outcome. We present a rare clinical presentation of a potentially fatal emerging disease that responded favorably to corticosteroids.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Climate change; Powassan virus; Rhombencephalitis

Year:  2020        PMID: 33227515     DOI: 10.1016/j.ijid.2020.11.159

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  2 in total

1.  "Double Trouble": Severe Meningoencephalitis Due to Borrelia burgdorferi and Powassan Virus Co-Infection Successfully Treated with Intravenous Immunoglobulin.

Authors:  Igor Dumic; Bridget Glomski; Janki Patel; Terri Nordin; Charles W Nordstrom; Lawrence J Sprecher; Eric Niendorf; Amteshwar Singh; Kosana Simeunovic; Anand Subramanian; Oladapo Igandan; Danilo Vitorovic
Journal:  Am J Case Rep       Date:  2021-03-24

2.  Powassan Encephalitis: A Case Report from New York, USA.

Authors:  Danielle A Bazer; Matthew Orwitz; Nicholas Koroneos; Olga Syritsyna; Elizabeth Wirkowski
Journal:  Case Rep Neurol Med       Date:  2022-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.